Q3 2023 · 13F-HR
SECTORAL ASSET MANAGEMENT INCholdings as filed
Filed 2023-11-14 · accession 0001104659-23-117467
$513.5M
Reported value
123
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 09061G101 | BMRN | BIOMARIN PHARMAC INC | $12.8M | 2.50% | 145,090 | Common | NONE |
| 532457108 | LLY | LILLY ELI & CO | $12.5M | 2.43% | 23,265 | Common | SOLE |
| 68404L201 | OPCH | OPTION CARE HEALTH | $12.1M | 2.37% | 375,500 | Common | NONE |
| 207410101 | CNMD | CONMED CORP | $11.5M | 2.24% | 114,000 | Common | NONE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP | $11.4M | 2.22% | 494,622 | Common | NONE |
| 77634L105 | RCM1USD | R1 RCM INC | $11.2M | 2.18% | 744,194 | Common | NONE |
| 42226A107 | HQY | HEALTHEQUITY INC | $10.5M | 2.05% | 143,875 | Common | NONE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $10.4M | 2.03% | 383,142 | Common | NONE |
| 750491102 | RDNT | RADNET INC | $10.4M | 2.03% | 369,134 | Common | NONE |
| 04963C209 | ATRC | ATRICURE INC | $10.4M | 2.02% | 236,532 | Common | NONE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS | $9.8M | 1.90% | 803,464 | Common | NONE |
| 05465P101 | AXNX* | AXONICS INC | $9.7M | 1.89% | 172,950 | Common | NONE |
| 45332Y109 | NARIUSD | INARI MED INC | $9.0M | 1.76% | 138,043 | Common | NONE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $8.9M | 1.72% | 56,850 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $8.8M | 1.71% | 347,392 | Common | NONE |
| 91324P102 | UNH | UNITEDHEALTH GRP INC | $8.5M | 1.66% | 16,925 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES | $8.3M | 1.62% | 165,890 | Common | NONE |
| G72800108 | PRTA | PROTHENA CORP PLC | $8.3M | 1.62% | 172,407 | Common | NONE |
| G4705A100 | ICLR | ICON PLC | $8.3M | 1.61% | 33,663 | Common | NONE |
| 603170101 | MLYS | MINERALYS THERAPEUTI | $8.0M | 1.56% | 840,759 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS | $7.9M | 1.54% | 181,904 | Common | NONE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEU | $7.8M | 1.51% | 386,525 | Common | NONE |
| 031162100 | AMGN | AMGEN INC | $7.5M | 1.47% | 28,065 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $7.4M | 1.43% | 464,112 | Common | NONE |
| G01767105 | ALKS | ALKERMES PLC | $6.8M | 1.33% | 244,260 | Common | NONE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES | $6.7M | 1.31% | 375,456 | Common | NONE |
| 46116X101 | ITCIEUR | INTRA CELLULAR THERA | $6.4M | 1.25% | 123,680 | Common | NONE |
| 92243G108 | PCVX | VAXCYTE INC | $6.2M | 1.20% | 121,230 | Common | NONE |
| 88033G407 | THC | TENET HEALTHCARE | $6.0M | 1.17% | 91,500 | Common | NONE |
| 00287Y109 | ABBV | ABBVIE INC | $5.9M | 1.14% | 39,300 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $5.9M | 1.14% | 36,725 | Common | NONE |
| 38246G108 | GDRX | GOODRX HLDGS INC | $5.7M | 1.10% | 1,007,000 | Common | NONE |
| 58933Y105 | MRK | MERCK & CO INC | $5.7M | 1.10% | 55,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERA | $5.6M | 1.09% | 97,965 | Common | NONE |
| 40637H109 | HALO | HALOZYME THERAPEUTIC | $5.6M | 1.09% | 146,000 | Common | NONE |
| 589889104 | MMSI | MERIT MEDICAL SYS | $5.5M | 1.06% | 79,000 | Common | NONE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICAL | $5.4M | 1.05% | 437,652 | Common | NONE |
| 24823R105 | DNLI | DENALI THERAPEUTICS | $5.3M | 1.02% | 254,941 | Common | NONE |
| 101137107 | BSX | BOSTON SCIENTIFIC | $5.2M | 1.02% | 98,976 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $5.2M | 1.02% | 157,400 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $5.2M | 1.01% | 69,000 | Common | NONE |
| 02043Q107 | ALNY | ALNYLAM PHARMACUETCL | $5.1M | 1.00% | 28,960 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $5.1M | 0.99% | 52,498 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.9M | 0.96% | 70,987 | Common | NONE |
| 92337R101 | VERA | VERA THERAPEUTICS | $4.9M | 0.95% | 357,139 | Common | NONE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $4.8M | 0.93% | 180,195 | Common | NONE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICA | $4.7M | 0.91% | 227,030 | Common | NONE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $4.6M | 0.90% | 271,056 | Common | NONE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUT | $4.5M | 0.87% | 985,000 | Common | NONE |
| 48576A100 | — | KARUNA THERAPEUTICS | $4.4M | 0.86% | 25,980 | Common | NONE |
| 004225108 | ACAD | ACADIA PHARMACEUTCLS | $4.4M | 0.85% | 209,960 | Common | NONE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUT | $4.2M | 0.82% | 157,552 | Common | NONE |
| 872381108 | TELA | TELA BIO INC | $4.2M | 0.82% | 525,000 | Common | NONE |
| 69366J200 | PTCT | PTC THERAPEUTICS I | $4.2M | 0.82% | 187,016 | Common | NONE |
| 74340E103 | PGNY | PROGYNY INC | $4.1M | 0.79% | 120,000 | Common | NONE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS | $4.0M | 0.77% | 1,049,191 | Common | NONE |
| 76155X100 | RVMD | REVOLUTION MEDICIN | $3.9M | 0.77% | 142,650 | Common | NONE |
| 09062X103 | BIIB | BIOGEN INC | $3.9M | 0.75% | 15,012 | Common | SOLE |
| 46266C105 | IQV | IQVIA HOLDINGS INC | $3.7M | 0.73% | 19,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCI | $3.6M | 0.71% | 7,165 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $3.6M | 0.69% | 7,325 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUT | $3.6M | 0.69% | 112,332 | Common | NONE |
| 23282W605 | CYTK | CYTOKINETICS INC | $3.5M | 0.68% | 118,303 | Common | NONE |
| 256086109 | DCGO | DOCGO INC | $3.5M | 0.68% | 651,400 | Common | NONE |
| 82489T104 | SWAVUSD | SHOCKWAVE MEDICAL | $3.5M | 0.67% | 17,400 | Common | NONE |
| 28176E108 | EW | EDWARDS LIFESCIENCE | $3.4M | 0.66% | 49,200 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS IN | $3.2M | 0.62% | 246,345 | Common | NONE |
| G5960L103 | MDT | MEDTRONIC PLC | $3.1M | 0.61% | 40,051 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES | $3.1M | 0.61% | 33,000 | Common | NONE |
| 75886F107 | REGN | REGENERON PHARMCTCLS | $3.1M | 0.60% | 3,720 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES I | $3.1M | 0.60% | 88,000 | Common | NONE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTI | $3.1M | 0.59% | 20,901 | Common | NONE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICL | $3.0M | 0.59% | 8,769 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX | $3.0M | 0.59% | 969,350 | Common | NONE |
| 252131107 | DXCM | DEXCOM INC | $3.0M | 0.58% | 31,700 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $2.9M | 0.56% | 38,150 | Common | SOLE |
| 235851102 | DHR | DANAHER CORP | $2.7M | 0.53% | 10,975 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG | $2.2M | 0.43% | 310,398 | Common | NONE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS | $2.2M | 0.43% | 18,006 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $2.1M | 0.41% | 898,785 | Common | NONE |
| 90042W100 | — | TURNSTONE BIOLOGICS | $2.0M | 0.40% | 517,648 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $2.0M | 0.38% | 9,210 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $1.9M | 0.37% | 47,000 | Common | NONE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS | $1.9M | 0.36% | 303,824 | Common | NONE |
| 556099109 | MGNX | MACROGENICS INC | $1.8M | 0.35% | 387,001 | Common | NONE |
| 78464A870 | XBI | SPDR SER TR | $1.8M | 0.35% | 24,675 | Common | NONE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS | $1.8M | 0.35% | 600,461 | Common | NONE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $1.7M | 0.34% | 770,132 | Common | NONE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS | $1.7M | 0.33% | 155,075 | Common | NONE |
| 046353108 | AZNN | ASTRAZENECA | $1.7M | 0.33% | 24,820 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $1.7M | 0.32% | 203,327 | Common | NONE |
| 60770K107 | MRNA | MODERNA INC | $1.5M | 0.30% | 15,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA IN | $1.5M | 0.29% | 432,339 | Common | NONE |
| 28202V108 | — | EFFECTOR THERAPEUTCS | $1.4M | 0.28% | 2,382,644 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMA | $1.4M | 0.27% | 176,080 | Common | NONE |
| 37148K100 | GBIOGBX | GENERATION BIO CO | $1.4M | 0.26% | 356,740 | Common | NONE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTIC | $1.3M | 0.26% | 73,655 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $1.3M | 0.25% | 375,960 | Common | NONE |
| 09077B104 | BCABGBP | BIOATLA INC | $1.2M | 0.23% | 706,062 | Common | NONE |
| 452327109 | ILMN | ILLUMINA INC | $864,864 | 0.17% | 6,300 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $688,201 | 0.13% | 12,830 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $603,230 | 0.12% | 1,227 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LIMITED | $599,327 | 0.12% | 3,332 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS | $590,650 | 0.12% | 2,615 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORPORATION | $557,192 | 0.11% | 9,645 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMA PLC | $506,628 | 0.10% | 3,914 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $487,163 | 0.09% | 17,950 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENC | $453,938 | 0.09% | 4,035 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $448,024 | 0.09% | 6,670 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A S | $397,127 | 0.08% | 4,241 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $374,265 | 0.07% | 3,445 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $355,621 | 0.07% | 30,447 | Common | SOLE |
| 92338C103 | VLTO | VERALTO CORPORATION | $309,320 | 0.06% | 3,658 | Common | SOLE |
| 256135203 | RDY | DR REDDYS LABS LTD | $300,915 | 0.06% | 4,500 | Common | SOLE |
| G46188101 | HZNPN | HORIZON THERAPEUTICS | $290,960 | 0.06% | 2,515 | Common | NONE |
| 58506Q109 | MEDP | MEDPACE HOLDINGS | $285,956 | 0.06% | 1,181 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $272,688 | 0.05% | 12,480 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTIC | $198,569 | 0.04% | 5,220 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTI | $148,972 | 0.03% | 57,297 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $137,676 | 0.03% | 7,010 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $72,930 | 0.01% | 3,000 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS | $37,400 | 0.01% | 20,000 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS | $23,136 | 0.00% | 4,357 | Common | NONE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.